LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.88 | 17.25 | 4764 | 5826 | 0.8177 | 0.9527 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.85 | 17.25 | 4065 | 5861 | 0.6935 | 0.9148 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.85 | 17.25 | 4106 | 5861 | 0.7005 | 0.9171 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.85 | 17.25 | 4887 | 5861 | 0.8337 | 0.9572 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.85 | 17.25 | 4929 | 5861 | 0.8409 | 0.9592 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.82 | 17.25 | 4321 | 5924 | 0.7294 | 0.9265 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.82 | 17.25 | 4363 | 5924 | 0.7365 | 0.9287 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.82 | 17.25 | 5083 | 5924 | 0.8580 | 0.9640 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.82 | 17.25 | 5116 | 5924 | 0.8636 | 0.9655 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.79 | 17.25 | 4453 | 6008 | 0.7411 | 0.9303 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.79 | 17.25 | 4490 | 6008 | 0.7473 | 0.9322 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.79 | 17.25 | 5261 | 6008 | 0.8756 | 0.9688 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.79 | 17.25 | 5295 | 6008 | 0.8813 | 0.9703 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.76 | 17.25 | 4685 | 6047 | 0.7747 | 0.9405 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.76 | 17.25 | 4722 | 6047 | 0.7808 | 0.9423 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.76 | 17.25 | 5490 | 6047 | 0.9078 | 0.9772 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.76 | 17.25 | 5521 | 6047 | 0.9129 | 0.9786 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 90.74 | 17.25 | 4836 | 6109 | 0.7915 | 0.9455 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 90.74 | 17.25 | 4871 | 6109 | 0.7973 | 0.9472 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 90.74 | 17.25 | 5711 | 6109 | 0.9348 | 0.9841 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 90.74 | 17.25 | 5739 | 6109 | 0.9394 | 0.9853 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 92.71 | 17.25 | 5040 | 6184 | 0.8150 | 0.9524 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 92.71 | 17.25 | 5071 | 6184 | 0.8200 | 0.9538 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 92.71 | 17.25 | 5881 | 6184 | 0.9510 | 0.9882 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 92.71 | 17.25 | 5903 | 6184 | 0.9545 | 0.9891 | MN20160310_N02 | F12 |